NBTY Tackles Direct Sales, European Expansion As Sales Grow 6%
This article was originally published in The Tan Sheet
Executive Summary
Nutritional supplement manufacturer and marketer NBTY's fiscal 2007 second-quarter sales increased 6 percent to $503 million and its net income grew 71 percent to $51 million as it closed North American and European retail sites while continuing to overhaul its direct-to-consumer sales operations
You may also be interested in...
Ad Strategies Spark Sales For Some NBTY Products, Miss Mark On Others
Effective promotion and advertising management generated positive second quarter results for nutritional supplement manufacturer and marketer NBTY, the company said in an earnings report released April 26
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Abbott's ‘Bedrock Of Good Health’ Nutritionals Business Faces Mounting Infant Formula Litigation
Nutritional product business had 5.1% Q1 sales growth and is like Abbott’s other segments, “super well-aligned to the global demographics and trends in health care,” says CEO Ford. But as it defends complaints of damages from powder formulas made at facility found with unsafe levels of bacterial contaminants, Abbott’s also targeted in litigation alleging failure to warn about risk of infants born prematurely developing necrotizing enterocolitis if fed cow’s milk-based formula.